The family of the IL-6-type cytokines: Specificity and promiscuity of the receptor complexes

Proteins: Structure, Function and Genetics

Volumn 27, Issue 1, 1997, Pages 96-109

  Grötzinger, Joachim ^a   Kurapkat, Günther ^a   Wollmer, Axel ^a   Kalai, Michael ^b   Rose John, Stefan ^c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

cytokines; gp130; IL 6 IL 6R complex; model building

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ARTICLE; CONFORMATIONAL TRANSITION; HUMAN; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN FOLDING; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

MURINAE;

EID: 0037987019     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(199701)27:1<96::AID-PROT10>3.0.CO;2-D     Document Type: Article

References (57)

1. Miyajima, A.T., Kitamura, T., Harada, N, Yokata, T., Arai, K. Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10:295-331, 1992.
2. Akira, S., Taga, T., Kishimoto, T. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1-72, 1993.
3. Mackiewicz, A., Koi, A., Sehgal, P. Interleukin-6-type cytokines. Ann. N.Y. Acad. Sci. 762:1-509, 1995.
4. Bazan, J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. U.S.A. 87:6934-6938, 1990.
5. Sprang, S.R., Bazan, J.F. Cytokine structural taxonomy and mechanisms of receptor engagement. Curr. Opin. Struct. Biol. 3:815-827, 1993.
6. De Vos, A.M., Ultsch, M., Kossiakoff, A.A. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255:306-312, 1992.
7. Robinson, R.C., Grey, L.M., Staunton, D., Vankelecom, H., Vernallis, A.B., Moreau, J.F., Stuart, D.I., Heath, J.K., Jones E.Y. The crystal structure and biological function of leukemia inhibitory factor: Implications for receptor binding. Cell 77:1101-1116, 1994.
8. McDonald, N.Q., Panayotatos, N., Hendrickson, W.A. Crystal structure of dimeric human ciliary neurotrophic factor determined by MAD phasing. EMBO J. 14:2689-2699, 1995.
9. Hill, C.P., Osslund, T.D., Eisenberg, D. The structure of granulocyte colony stimulating factor and its relationship to other growth factors. Proc. Natl. Acad. Sci. U.S.A. 90: 5167-5171, 1993.
10. Zink, T., Ross, A., Lüers, K., Cieslar, C., Rudolph, R., Holak, T.A. Structure and dynamics of the human granulocyte colony stimulating factor determined by NMR spectroscopy: Loop mobility in a four-helix bundle protein. Biochemistry 33:8453-463, 1994.
11. Ehlers, M., Grötzinger, J., de Hon, F.D., Mullberg, J., Brakenhoff, J.P.J., Liu, J.W., Wollmer, A., Rose-John, S. Identification of two novel regions of hIL-6 responsible for receptor binding and signal transduction. J. Immunol. 153: 1744-1753, 1994.
12. Ehlers, M., de Hon, F.D., Bos, K.H., Horsten, U., Kurapkat, G., Schmitz van De Leurs, H., Grötzinger, J., Wollmer, A., Brakenhoff, J.P.J., Rose-John, S. Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells. J. Biol. Chem. 270:8158-8163, 1995.
13. Savino, R., Lahm, A., Salvati, A.L., Ciapponi, L., Sporeno, E., Altamura, S., Paonessa, G., Toniatti, C., Ciliberto, G. Generation of interleukin-6 receptor antagonists by molecular modeling guided mutagenesis of residues important for gp130 activation. EMBO J. 13:1357-1367, 1994a.
14. Savino, R., Ciapponi, L., Lahm, A., Demartis, A., Cabibbo, A., Toniatti, C., Delmastro, P., Altamura, S., Ciliberto, G. Rational design of a receptor superantagonist of human interleukin-6. EMBO J. 13:5863-5870, 1994b.
15. Krüttgen, A., Grötzinger, J., Kurapkat, G., Weiss, J., Simon, R., Thier, M., Schröder, M., Heinrich, P.C., Wollmer, A., Comeau, M., Müllberg, J., Rose-John, S. Human ciliary neurotrophic factor: A structure-function analysis. Biochem. J. 309:215-220, 1995.
16. Cosman, D., Lyman, S.D., Idzerda, R.L., Beckmann, M.P., Park, L.S., Goodwin, R.G., March, C.J. A new cytokine receptor superfamily. Trends Biochem. Sci. 15:265-270, 1990.
17. Horsten, U., Schmitz van De Leur, H., Müllberg, J., Heinrich, P.C., Rose-John, S. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor. FEBS Lett 360:43-46, 1995.
18. Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T., Kishimoto, T. IL-6 induced homodimerization of gp130. Science 260:1808-1810, 1993.
19. Somers, W., Ultsch, M., De Vos, A.M., Kossiakoff, A.A. The x-ray structure of a growth hormone prolactin receptor complex. Nature 372:478-481,1994.
20. Paonessa, G., Graziani, R., De Serio, A., Savino, R., Ciapponi, L., Lahm, A., Salvati, A.L., Toniatti, C., Ciliberto, G. Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling. EMBO J. 14:1942-1951, 1995.
21. Van Snick, J. Interleukin-6: An overview. Annu. Rev. Immunol. 8:253-279, 1990.
22. Brakenhoff, J.P.J., de Hon, F.D., Fontaine, V., ten Boekel, E., Schooltink, H., Rose-John, S., Heinrich, P.C., Content, J., Aarden, L.A. Development of a human interleukin-6 receptor antagonist. J. Biol. Chem. 269:86-93, 1994.
23. de Hon, Klaasse Bos, H., Ebeling, S.B., Grötzinger J., Kurapkat, G., Rose-John, S., Aarden, L.A., Brakenhoff, J.P.J. Leucine-58 in the putative 5th helical region of human interleukin (IL)-6 is important for activation of the IL-6 signal transducer, gp130. FEBS Lett. 369:187-191, 1995.
24. Ehlers, M., Grötzinger, J., Fischer, M., Bos, H.K., Brakenhoff, P.J., Rose-John, S. Identification of single amino acid residues of human Interleukin-6 involved in receptor binding and signal initiation. J. Interferon Cytokine Res. 16: 569-576, 1996.
25. Brakenhoff, J.P.J., Hart, M., Aarden, L.A. Analysis of hIL-6 mutants expressed in Escherichia coli: Biologic activities are not affected by deletion of amino acids 1-28. J. Immunol. 143:1175-1182, 1989.
26. Brakenhoff, J.P.J., Hart, M., de Groot, E.R., Di Padova, F., Aarden, L.A. Structure-function analysis of human IL-6: Epitope mapping of neutralizing monoclonal antibodies with amino and carboxyl terminal deletion mutants. J. Immunol. 145:561-568, 1990.
27. Fontaine, V., Dewit, L., Brakenhoff, J., Content, J. Structure-function studies of human interleukin-6. Mol. Cell. Biol. Cytokines 10:45-50, 1990.
28. Krüttgen, A., Rose-John, S., Dufhues, G., Bender, S., Lütticken, C., Freyer, P., Heinrich, P.C. The three carboxy terminal amino acids of human interleukin-6 are essentials for its biological activity. FEBS Lett. 273:95-98, 1990.
29. Krüttgen, A., Rose-John, S., Möller, C., Wroblowski, B., Wollmer, A., Müllberg, J., Hirano, T., Kishimoto, T., Heinrich, P.C. Structure-function analysis of human interleukin-6: Evidence for the involvement of the carboxy terminus in function. FEBS Lett. 262:323-326, 1990.
30. Lütticken, C., Krüttgen, A., Möller, C., Heinrich, P.C., Rose-John, S. Evidence for the importance of a positive charge and an α-helical structure of the C-terminus for biological acitvity of human IL-6. FEBS Lett. 282:265-267,1991.
31. Fontaine, V., Savino, R., Arcone, R., Dewit, L., Brakenhoff, J., Content, J., Ciliberto, G. Involvement of the Arg179 in the active site of human IL-6. Eur. J. Biochem. 211:749-755, 1993.
32. Van Dam, M., Müllberg, J., Schooltink, H., Stoyan, T., Brakenhoff, J.P.G., Graeve, L., Heinrich, P.C., Rose-John, S. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules: Involvement of two separate domains in receptor binding. J. Biol. Chem. 268: 15285-15290, 1993.
33. de Hon, F.D., Ehlers, M., Rose-John, S., Ebeling, S., Bos, H.K., Aarden, L.A., Brakenhoff, J.P.J. Development of an interleukin (IL)-6 receptor antagonist that inhibits IL-6 dependent growth of human myeloma cells. J. Exp. Med. 180:2395-2400, 1994.
34. Yawata, H., Yasukawa, K., Natsuka, S., Murakami, M., Yamasaki, K., Hibi, M., Taga, T., Kishimoto, T. Structure-function analysis of human IL-6 receptor: Dissociation of amino acid residues required for IL-6 binding and for IL-6 signal transduction through gp130. EMBO J. 12:1705-1712, 1993.
35. Kalai, M., MonteroJulian, F.A., Grötzinger, J., Wollmer, A., Morelle, D., Brochier, J., Rose-John, S., Heinrich, P.C., Brailly, H., Content, J. Participation of two Ser-Ser-Tyr-Tyr repeats in IL-6 binding sites of human interleukin-6 receptor. Eur. J. 238:714-723, 1996.
36. Weiergräber, O., Schneider-Mergener, J., Grötzinger, J., Wollmer, A., Küster, A., Exner, M., Heinrich, P.C. Use of immobilized synthetic peptides for the identification of contact sites between human interleukin-6 and its receptor. FEBS Lett. 379:122-126, 1995.
37. Ward, L.D., Howlett, G.J., Discolo, G., Yasukawa, K., Hammacher, A., Moritz, R.L., Simpson, R.J. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp130. J. Biol. Chem. 269:23286-23289, 1994.
38. Husar program package, EMBL, Heidelberg, Germany.
39. Rost, B., Sander, C. Combining evolutionary information and neural networks to predict protein secondary structure. Proteins 19:55-72, 1994.
40. Vriend, G. WHAT IF: A molecular modeling and drug design program. J. Mol. Graph. 8:52-6, 1990.
41. an Gunsteren, W.F. Distributed by BIOMOS biomolecular software b.v.,Laboratory of Physical Chemistry, University of Groningen, The Netherlands).
42. Carson, M. Ribbons 2.0. J. Appl. Crystallogr. 24:946-950, 1991.
43. Clackson, T., Wells, J.A. A hot spot of binding energy in a hormone receptor interface. Science 267:383-386, 1995.
44. Wells, J.A. Structural and functional epitopes in the growth hormone receptor complex. Biotechnology 13:647-651, 1995.
45. Savino, R., Lahm, A., Giogio, M., Cabibbo, A., Tramontano, A., and Ciliberto, G. Saturation mutagenesis of the human interleukin-6 receptor binding site: Implications for its three-dimensional structure. Proc. Natl. Acad. Sci. U.S.A. 90:4067-4071, 1993.
46. Nishimura, C., Ekida, T., Nomura, K., Sakamoto, K., Suzuki, H., Yasukawa, K., Kishimoto, T., Arata, Y. Role of leucine residues in the C-terminal region of human interleukin-6 in the biological activity. FEBS Lett. 311:271-275, 1992.
47. Kalai, M., Montero-Julian, F.A., Grötzinger, J., Fontaine, V., Vandenbussche, P., Deschuyteneer, R., Wollmer, A., Brailly, H., Content, J. Analysis of the IL-6/IL-6 binding interface at the amino acid level. Proposed mechanisms of interaction. Blood (in press)
48. Fontaine, V., Ooms, J., Content, J. Mutagenesis of the human interleukin-6 fourth predicted alpha helix: Involvement of the Arg168 in the binding site. Eur. J. Immunol. 24:1041-1045, 1994.
49. Salvati, A.L., Lahm, A., Paonessa, G., Ciliberto, G., Toniatti, C. Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130 binding interface. J. Biol. Chem. 270:12242-12249, 1995.
50. Leebeek, F.W.G., Kariya, K., Schwabe, M., Fowlkes, D.M. Identification of a receptor binding site in the carboxyl terminus of human interleukin-6. J. Biol. Chem. 267: 14832-14838, 1992.
51. de Hon, F. "Development and Characterization of Human Interleukin-6 Receptor Antagonists." Dissertation. Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, University of Amsterdam, The Netherlands, 1995.
52. Panayotatos, N., Radziejewska, E., Acheson, A., Somogyi, R., Thadani, A., Hendrickson, W.A., McDonald, N.Q. Localization of functional receptor epitopes on the structure of ciliary neurotrophic factor indicates a conserved, function-related epitope topography among helical cytokines. J. Biol. Chem. 270:14007-14014, 1995.
53. De Serio, A., Graziani, R., Laufer, R., Ciliberto, G., Paonessa, G. In vitro binding of ciliary neurotrophic factor to its receptors: Evidence for the formation of an IL-6-type hexameric complex. J. Mol. Biol. 254:795-800, 1995.
54. Grube, B.J., Cochrane, C.G. Indentification of a regulatory domain of the interleukin-6 receptor. J. Biol. Chem. 269: 20791-20797, 1994.
55. Leebeck, F.W.G., Fowlkes, D.M. Construction and functional analysis of hybrid interleukin-6 variants. FEBS Lett. 306:262-264, 1992.
56. Arcone, R., Fontaine, V., Coto, I., Brakenhoff, J.P.J., Content, J., Ciliberto, G. Internal deletions of amino acids 29-42 of human interleukin-6 (IL-6) differentially affect bioactivity and folding. FEBS Lett. 288:197-200, 1991.
57. Ehlers, M., Grötzinger J., de Hon, F.D., Müllberg, J., Brakenhoff, J.P.J., Wollmer, A., Rose-John, S. Residues 77-95 of the human interleukin-6 protein are responsible for receptor binding and residues 41-56 for signal transduction. Ann. N.Y. Acad. Sci. 762:400-402, 1995.